SPECTRAL MEDICAL INC (EDT.CA) Stock Overview
TSX:EDT - CA8475771033 - Common Stock
EDT.CA Key Statistics, Chart & Performance
The current stock price of EDT.CA is 1.49 CAD. In the past month the price increased by 79.52%. In the past year, price increased by 125.76%.
EDT.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 343.98M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 266.82M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 204.61M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 126.12M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 103.88M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 97.56M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 90.92M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 66.41M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 18.46 | 65.81M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 60.21M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 45.90M |
Related stock screener links
About EDT.CA
Company Profile
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The firm also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. The company provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
Company Info
SPECTRAL MEDICAL INC
135 The West Mall, Unit 2
TORONTO ONTARIO M9C 1C2 CA
CEO: Chris Seto
Employees: 29
Phone: 14166263233
SPECTRAL MEDICAL INC / EDT.CA FAQ
What is the stock price of SPECTRAL MEDICAL INC today?
The current stock price of EDT.CA is 1.49 CAD. The price increased by 0.68% in the last trading session.
What is the ticker symbol for SPECTRAL MEDICAL INC stock?
The exchange symbol of SPECTRAL MEDICAL INC is EDT and it is listed on the Toronto Stock Exchange exchange.
On which exchange is EDT.CA stock listed?
EDT.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for SPECTRAL MEDICAL INC stock?
5 analysts have analysed EDT.CA and the average price target is 2.75 CAD. This implies a price increase of 84.83% is expected in the next year compared to the current price of 1.49. Check the SPECTRAL MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SPECTRAL MEDICAL INC worth?
SPECTRAL MEDICAL INC (EDT.CA) has a market capitalization of 425.87M CAD. This makes EDT.CA a Small Cap stock.
How many employees does SPECTRAL MEDICAL INC have?
SPECTRAL MEDICAL INC (EDT.CA) currently has 29 employees.
What are the support and resistance levels for SPECTRAL MEDICAL INC (EDT.CA) stock?
SPECTRAL MEDICAL INC (EDT.CA) has a support level at 0.85. Check the full technical report for a detailed analysis of EDT.CA support and resistance levels.
Is SPECTRAL MEDICAL INC (EDT.CA) expected to grow?
The Revenue of SPECTRAL MEDICAL INC (EDT.CA) is expected to grow by 14.29% in the next year. Check the estimates tab for more information on the EDT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SPECTRAL MEDICAL INC (EDT.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EDT.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EDT.CA, evaluating the profitability, health, valuation and growth aspects
- SPECTRAL MEDICAL INC (EDT.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SPECTRAL MEDICAL INC (EDT.CA) Sales and EPS estimates to see what analysts future expectations are.
- SPECTRAL MEDICAL INC (EDT.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SPECTRAL MEDICAL INC (EDT.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SPECTRAL MEDICAL INC (EDT.CA) Stock Chart to make your own analysis
- SPECTRAL MEDICAL INC (EDT.CA) Latest news and press-releases to stay up to date.
Does SPECTRAL MEDICAL INC (EDT.CA) stock pay dividends?
EDT.CA does not pay a dividend.
When does SPECTRAL MEDICAL INC (EDT.CA) report earnings?
SPECTRAL MEDICAL INC (EDT.CA) will report earnings on 2025-11-06.
What is the Price/Earnings (PE) ratio of SPECTRAL MEDICAL INC (EDT.CA)?
SPECTRAL MEDICAL INC (EDT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
EDT.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to EDT.CA. When comparing the yearly performance of all stocks, EDT.CA is one of the better performing stocks in the market, outperforming 93.5% of all stocks.
EDT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA. EDT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
EDT.CA Financial Highlights
Over the last trailing twelve months EDT.CA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS decreased by -17.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -388.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EDT.CA Forecast & Estimates
5 analysts have analysed EDT.CA and the average price target is 2.75 CAD. This implies a price increase of 84.83% is expected in the next year compared to the current price of 1.49.
For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 14.29% for EDT.CA